REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.78
Bid: 42.72
Ask: 42.80
Change: 0.18 (0.42%)
Spread: 0.08 (0.187%)
Open: 42.26
High: 42.94
Low: 42.26
Prev. Close: 42.60
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Refinancing of RCF & new sustainability linkage

9 Oct 2023 07:00

RNS Number : 0389P
Assura PLC
09 October 2023

9 October 2023

Assura plc

Refinancing of RCF & new sustainability linkage

Assura plc ("Assura"), the leading primary care property investor and developer, today announces it has refinanced its revolving credit facility ("RCF" or "facility").

The new facility provides Assura with improved terms and flexibility compared to the existing agreement:

- increased from £125 million to £200 million and matures in October 2026

- reduced margin (headline rate 135 basis points with ratchet based on leverage) and overall cost, reflecting the strength of the business

- ability to draw facility in both GBP and EUR

- option to extend the facility by two additional one-year terms (to October 2028), subject to lender approval.

Reflecting Assura's long-term social impact and sustainability targets, the RCF now also includes sustainability-linked KPIs and commitments. Achievement of these KPIs, which are aligned with the existing targets of the business, will result in the margin being adjusted up or down by 5 basis points and the difference being donated to the Assura Community Fund.

The RCF is provided by Barclays Bank PLC, HSBC UK Bank plc, National Westminster Bank plc and Santander UK plc. Assura was advised by Rothschild & Co and Addleshaw Goddard.

Jayne Cottam, CFO, said:

"We are delighted to have increased our RCF to £200 million, extending the long-term relationship we have with our lenders. As well as improving the terms, reflecting the strength of our business, this agreement locks in flexible financing for our future activities.

"Following this agreement, £800 million of our committed facilities now have a sustainability-linkage, aligning our financing with our ambitious ESG targets that are intrinsic to Assura's business model."

- ENDS -

Assura plc David Purcell, Investor Relations Director

Tel: 0161 515 2043 Email: Investor@assura.co.uk

FGS Global

Gordon Simpson

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTZZMGGVVGGFZM
Date   Source Headline
13th Jul 20227:00 amRNSDirector/PDMR Shareholding
12th Jul 20227:00 amRNSAdditional Listing
11th Jul 20227:00 amRNSScrip Dividend Declaration
7th Jul 20228:07 amRNSHolding(s) in Company
6th Jul 20225:18 pmRNSDirector/PDMR Shareholding
6th Jul 20225:06 pmRNSHolding(s) in Company
6th Jul 20223:32 pmRNSResult of AGM
6th Jul 20228:57 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSTrading Update
16th Jun 20229:45 amRNSScrip Calculation Price
7th Jun 20227:00 amRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSAnnual Report & Notice of AGM
31st May 20221:58 pmRNSDirector/PDMR Shareholding
31st May 20227:00 amRNSNotice of Dividend
24th May 20227:00 amRNSAssura Full Year Results 2022
17th May 20225:41 pmRNSHolding(s) in Company
16th May 20224:36 pmRNSChange to year end results announcement date
12th May 20225:15 pmRNSHolding(s) in Company
12th May 20227:00 amRNSUpdated results presentation timing
9th May 20229:06 amRNSDirector/PDMR Shareholding
6th May 202211:46 amRNSHolding(s) in Company
4th May 20223:17 pmRNSHolding(s) in Company
4th May 20229:31 amRNSHolding(s) in Company
29th Apr 202211:58 amRNSTotal Voting Rights
29th Apr 202211:56 amRNSHolding(s) in Company
22nd Apr 20227:00 amRNSIssue of Consideration Shares
21st Apr 20223:01 pmRNSDirector/PDMR Shareholding
21st Apr 20227:00 amRNSNotice of Results & Investor Presentations
12th Apr 20228:50 amRNSHolding(s) in Company
11th Apr 202211:10 amRNSDirector/PDMR Shareholding
11th Apr 20228:47 amRNSHolding(s) in Company
11th Apr 20227:00 amRNSScrip Dividend Declaration
6th Apr 202210:30 amRNSStandard form for notification of major holdings
6th Apr 20227:00 amRNSIssue of Consideration Shares
1st Apr 20227:00 amRNSDevelopment Update
22nd Mar 202210:07 amRNSHolding(s) in Company
18th Mar 20221:49 pmRNSScrip Calculation Price
16th Mar 20227:00 amRNSDevelopment Update
8th Mar 20222:57 pmRNSHolding(s) in Company
8th Mar 20222:01 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSNotice of Dividend
9th Feb 20223:52 pmRNSHolding(s) in Company
9th Feb 20221:15 pmRNSDirector/PDMR Shareholding
1st Feb 20229:08 amRNSTotal Voting Rights
18th Jan 20223:14 pmRNSDirector/PDMR Shareholding
10th Jan 20227:00 amRNSScrip Dividend Declaration
10th Jan 20227:00 amRNSTrading Update
7th Jan 20223:41 pmRNSDirector/PDMR Shareholding
16th Dec 20219:27 amRNSScrip Calculation Price
8th Dec 20214:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.